首页> 外国专利> EVOKING PROTECTION AGAINST STREPTOTOCCUS PNEUMONIAE INCORPORATING B-CELL AND T-CELL PNEUMOCOCCAL PROTEIN ANTIGENS AND PNEUMOCOCCAL POLYSACCHARIDES DELIVERED CONCOMITANTLY

EVOKING PROTECTION AGAINST STREPTOTOCCUS PNEUMONIAE INCORPORATING B-CELL AND T-CELL PNEUMOCOCCAL PROTEIN ANTIGENS AND PNEUMOCOCCAL POLYSACCHARIDES DELIVERED CONCOMITANTLY

机译:引起对包括肺炎链球菌在内的B细胞和T细胞肺炎蛋白抗原和肺炎球菌多糖的保护

摘要

This disclosure is directed to compositions that combine the polysaccharide-specific antibody protection afforded by the conventional vaccines through carrier effects provided by one or more pneumococcal common T-cell antigen(s) together with Streptococcus pneumoniae-specific Th-17 responses elicited by the pneumococcal carrier common T-cell antigen. The disclosed compositions are useful for pan-serotypic protection against NP carriage, and antibody responses against common pneumococcal virulence factors, potentially useful for pan-serotype protection against Streptococcus pneumoniae invasive diseases.
机译:本公开内容涉及组合物,其组合了常规疫苗通过一种或多种肺炎球菌常见T细胞抗原与肺炎链球菌特异性Th提供的载体作用而提供的多糖特异性抗体保护。肺炎球菌载体常见的T细胞抗原引发-17反应。所公开的组合物可用于针对NP携带的全血清型保护,以及针对常见肺炎球菌毒力因子的抗体应答,其可能用于针对肺炎链球菌侵袭性疾病的全血清型保护。

著录项

  • 公开/公告号US2015079132A1

    专利类型

  • 公开/公告日2015-03-19

    原文格式PDF

  • 申请/专利权人 PATH;

    申请/专利号US201414489104

  • 申请日2014-09-17

  • 分类号A61K39/09;

  • 国家 US

  • 入库时间 2022-08-21 15:25:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号